Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood-brain barrier disruption in multiple sclerosis

Bibiana Bielekova, Nancy Richert, Thomas Howard, Amy N. Packer, Gregg Blevins, Joan Ohayon, Henry F. McFarland, Claus Steffen Stürzebecher, Roland Martin

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood-brain barrier disruption in multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences